{"organizations": [], "uuid": "2dd0f3fc81bb1e27e2b57f6b09cf1cbdce57bbba", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180326.html", "section_title": "Archive News &amp; Video for Monday, 26 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-aslan-pharmaceuticals-files-for-us/brief-aslan-pharmaceuticals-files-for-u-s-ipo-idUSEMN4BZZA6", "country": "US", "domain_rank": 408, "title": "BRIEF-Aslan Pharmaceuticals Files For U.S. IPO", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.037, "site_type": "news", "published": "2018-03-27T04:32:00.000+03:00", "replies_count": 0, "uuid": "2dd0f3fc81bb1e27e2b57f6b09cf1cbdce57bbba"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-aslan-pharmaceuticals-files-for-us/brief-aslan-pharmaceuticals-files-for-u-s-ipo-idUSEMN4BZZA6", "ord_in_thread": 0, "title": "BRIEF-Aslan Pharmaceuticals Files For U.S. IPO", "locations": [], "entities": {"persons": [{"name": "leerink", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "aslan pharmaceuticals", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "aslan pharmaceuticals ltd", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "h.c. wainwright & co", "sentiment": "none"}, {"name": "clsa are among underwriters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 26 (Reuters) - Aslan Pharmaceuticals Ltd :\n* ASLAN PHARMACEUTICALS LIMITED FILES FOR U.S. IPO OF UP TO $86.3 MILLION – SEC FILING\n* ASLAN PHARMACEUTICALS LIMITED SAYS IT INTENDS TO APPLY TO HAVE ITS ADS LISTED ON NASDAQ GLOBAL MARKET UNDER THE SYMBOL “ASLN”\n* ASLAN PHARMACEUTICALS LIMITED SAYS LEERINK PARTNERS, PIPER JAFFRAY ARE AMONG UNDERWRITERS TO IPO\n* ASLAN PHARMACEUTICALS LIMITED SAYS BTIG, H.C. WAINWRIGHT & CO, CLSA ARE AMONG UNDERWRITERS TO IPO\n* ASLAN PHARMACEUTICALS LIMITED SAYS PROPOSED IPO PRICE IS AN ESTIMATE SOLELY FOR CALCULATING SEC REGISTRATION FEE Source text : ( bit.ly/2ISrDXD )\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "https://bit.ly/2ISrDXD", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-03-27T04:32:00.000+03:00", "crawled": "2018-03-27T11:55:59.060+03:00", "highlightTitle": ""}